FDA Review of Pharma Ads Could Reshape D2C Marketing

Fri, 17 Jul 2026 12:00:00 -0400
Marketing News

The FDA is proposing a rule that could force prescription drug TV and radio ads to include all risk and safety information within the spot itself. The change may reshape pharma D2C campaign strategy, creative development, and media buying across a market that spent nearly $6 billion on national TV drug ads in 2025.